G1 Therapeutics Inc (GTHX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 32,281 | 94,657 | 221,249 | 207,369 | 269,271 |
| Marketable Securities | 49,938 | 50,476 | 0 | N/A | N/A |
| Receivables | 12,687 | 11,094 | 5,688 | 237 | N/A |
| Inventories | 12,442 | 16,179 | 3,471 | N/A | N/A |
| TOTAL | $114,948 | $179,500 | $243,565 | $216,392 | $271,003 |
| Non-Current Assets | |||||
| PPE Net | 1,476 | 1,989 | 2,013 | 2,482 | 3,538 |
| Other Non-Current Assets | 5,116 | 6,476 | 8,516 | 9,678 | 10,290 |
| TOTAL | $6,592 | $8,465 | $10,529 | $12,160 | $13,828 |
| Total Assets | $121,540 | $187,965 | $254,094 | $228,552 | $284,831 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,992 | 7,431 | 2,897 | 3,572 | 3,684 |
| Accrued Expenses | 21,893 | 25,557 | 23,180 | 16,486 | 15,403 |
| Other current liabilities | 3,211 | 2,593 | 1,505 | 3,148 | 682 |
| TOTAL | $29,716 | $35,588 | $27,613 | $23,443 | $19,769 |
| Non-Current Liabilities | |||||
| Long Term Debt | 51,557 | 77,015 | 75,190 | 19,893 | N/A |
| Deferred Revenues | 620 | 7 | 31 | 237 | N/A |
| Other Non-Current Liabilities | 4,381 | 5,615 | 6,750 | 7,865 | 9,535 |
| TOTAL | $56,438 | $83,630 | $82,940 | $27,758 | $9,535 |
| Total Liabilities | $86,154 | $119,218 | $110,553 | $51,201 | $29,304 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 52,199 | 51,658 | 42,706 | 41,959 | 37,642 |
| Common Shares | 5 | 5 | 4 | 4 | 4 |
| Retained earnings | -779,985 | -732,018 | -584,459 | -436,107 | -336,853 |
| Other shareholders' equity | -8 | -8 | -8 | -8 | -8 |
| TOTAL | $35,386 | $68,747 | $143,541 | $177,351 | $255,527 |
| Total Liabilities And Equity | $121,540 | $187,965 | $254,094 | $228,552 | $284,831 |